CLYM peer analysis
Climb Bio (CLYM) against its competitors: price, today's move, 1-year return and market value side by side.
CLYM and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CABA Cabaletta Bio | $1.34 | 4.66% | -53.52% | $240.75M |
| ELDN Eledon Pharmaceuticals | $2.60 | 5.89% | -40.99% | – |
| TRAX First Tracks Biotherapeutics | $49.00 | 7.86% | – | – |
| UPB Upstream Bio | $3.21 | 0.16% | -86.50% | – |
| CLYM Climb Bio | $10.34 | 16.57% | 371.28% | – |
- CLYM's peers: CABA (Cabaletta Bio), ELDN (Eledon Pharmaceuticals), TRAX (First Tracks Biotherapeutics), UPB (Upstream Bio).
Updated 2026-11-07 11:55 UTC